Covalon Technologies (OTCMKTS:CVALF) Trading 2.2% Higher - Time to Buy?

Covalon Technologies Ltd. (OTCMKTS:CVALF - Get Free Report) rose 2.2% on Monday . The company traded as high as $1.86 and last traded at $1.86. Approximately 2,000 shares changed hands during trading, a decline of 88% from the average daily volume of 16,468 shares. The stock had previously closed at $1.82.

Covalon Technologies Stock Up 1.3%

The business's 50 day moving average is $1.72 and its two-hundred day moving average is $2.06. The firm has a market capitalization of $54.84 million, a P/E ratio of 28.58 and a beta of 0.49.

Covalon Technologies (OTCMKTS:CVALF - Get Free Report) last posted its quarterly earnings data on Friday, February 21st. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.06. The business had revenue of $5.84 million during the quarter, compared to analysts' expectations of $6.37 million. Covalon Technologies had a net margin of 8.58% and a return on equity of 12.33%.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.